Table 3

Univariate and multivariate association between smoking and cytokine levels in patients with SLE

UnivariateAge and sex adjustedModel 1Model 2
RsP valueB (95% CI)P valueB (95% CI)P valueB (95% CI)P value
Ln(BAFF)0.200.0430.24 (0.03 to 0.45)0.0230.25 (0.05 to 0.45)0.0150.27 (0.06 to 0.48)0.014
Ln(IFN-γ)0.320.0010.79 (−1.25 to 0.32)0.0010.80 (−1.27 to 0.33)0.0010.42 (−0.79 to 0.05)0.026
Ln(IL-1β)−0.190.0540.42 (-0.82 to 0.02)0.039−0.38 (−0.78 to 0.02)0.062–*
Ln(IL-4)0.250.015−0.47 (0.98 to 0.02)0.060−0.43 (−0.92 to 0.07)0.089−0.03 (−0.27 to 0.20)**−0.778
Ln(IL-6)−0.150.142−0.26 (−0.61 to 0.09)0.088−0.24 (−0.59 to 0.11)0.183−0.06 (−0.35 to 0.23)0.666
Ln(IL-10)−0.040.725−0.42 (−0.96 to 0.12)0.123−0.35 (−0.89 to 0.18)0.1950.03 (−0.28 to 0.35)#0.832
Ln(IL-12)−0.190.0550.51 (−0.93 to 0.08)0.0210.46 (−0.89 to 0.03)0.038−0.09 (−0.41 to 0.22)0.588
Ln(IL-17)−0.120.2370.43 (−0.80 to 0.06)0.0220.41 (−0.78 to 0.03)0.034−0.20 (−0.46 to 0.07)0.146
Ln(MCP-1)−0.160.104−0.24 (−0.55 to 0.07)0.129−0.24 (−0.56 to 0.07)0.124−0.12 (−0.43 to 0.19)0.435
Ln(TNF-α)0.240.0160.55 (−0.99 to 0.11)0.0140.54 (−0.98 to 0.09)0.019−0.25 (−0.60 to 0.10)0.155
Ln(TGF-β1)−0.170.1−0.20 (−0.41 to 0.02)0.076−0.21 (−0.43 to 0.01)0.062−0.18 (−0.41 to 0.05)%0.118
Ln(MIP-1α)−0.130.21−0.28 (−0.90 to 0.35)0.381−0.19 (−0.81 to 0.43)0.550.16 (−0.41 to 0.73)0.580
Ln(MIP-1β)0.270.0070.27 (−0.49 to 0.06)0.0110.26 (−0.47 to 0.05)0.014−0.13 (−0.31 to 0.05)0.159
  • Model 1 adjusted for age, sex, prednisone use, immunosuppressant use, SLEDAI score, SDI score.

  • Model 2 adjusted for model 1 plus (regulatory cytokine) IL-1β* and anti-inflammatory cytokines (IL-4**, IL-10# and TGF-β%) (*, **, #, % indicate that this cytokine was dropped from the independent variables of the model).

  • Bolded findings: current smoking associated with changes (+/-) in the level of the cytokine of interest smoking.

  • BAFF, B cell-activating factor; IFN-γ, interferon-gamma; IL, interleukin; MCP-1, monocyte chemoattractant protein 1; MIP-1α, macrophage inflammatory protein 1 alpha; MIP-1β, macrophage inflammatory protein 1 beta; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; SLEDAI, SLE Disease Activity Index; TGF-β1, transforming growth factor beta 1; TNF-α, tumour necrosis factor-alpha.